Exact Sciences Corp (NASDAQ:EXAS) Institutional Investors Sentiment

July 18, 2017 - By Linda Rogers

 Exact Sciences Corp (NASDAQ:EXAS) Institutional Investors Sentiment

Sentiment for Exact Sciences Corp (NASDAQ:EXAS)

Exact Sciences Corp (NASDAQ:EXAS) institutional sentiment decreased to 1.08 in 2016 Q4. Its down -0.40, from 1.48 in 2016Q3. The ratio fall, as 98 investment managers increased and opened new stock positions, while 91 sold and decreased their equity positions in Exact Sciences Corp. The investment managers in our partner’s database reported: 88.31 million shares, up from 87.34 million shares in 2016Q3. Also, the number of investment managers holding Exact Sciences Corp in their top 10 stock positions decreased from 3 to 2 for a decrease of 1. Sold All: 35 Reduced: 56 Increased: 67 New Position: 31.

Exact Sciences Corporation is a molecular diagnostics company. The company has market cap of $4.54 billion. The Firm focuses on the early detection and prevention of some forms of cancer. It currently has negative earnings. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer.

The stock increased 0.13% or $0.05 during the last trading session, reaching $38.64. About shares traded. EXACT Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since July 18, 2016 and is uptrending. It has outperformed by 441.54% the S&P500.

Wall Street await EXACT Sciences Corporation (NASDAQ:EXAS) to release earnings on July, 25. Analysts forecast earnings per share of $-0.37, up exactly $0.09 or 19.57 % from 2014’s $-0.46 EPS. After posting $-0.32 EPS for the previous quarter, EXACT Sciences Corporation’s analysts now forecast 15.63 % negative EPS growth.

Sanctuary Wealth Advisors Llc holds 2.88% of its portfolio in EXACT Sciences Corporation for 242,715 shares. Shannon River Fund Management Llc owns 550,000 shares or 2.29% of their US portfolio. Moreover, Thompson Investment Management Inc. has 1.57% invested in the company for 600,294 shares. The China-based J&P(China)Capital Management Co.Ltd has invested 1.54% in the stock. Zevenbergen Capital Investments Llc, a Washington-based fund reported 2.33 million shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 9 sales for $1.67 million activity.

EXACT Sciences Corporation (NASDAQ:EXAS) Ratings Coverage

Ratings analysis reveals 57% of EXACT Sciences’s analysts are positive. Out of 14 Wall Street analysts rating EXACT Sciences, 8 give it “Buy”, 1 “Sell” rating, while 5 recommend “Hold”. The lowest target is $4 while the high is $5000. The stock’s average target of $27.86 is -27.90% below today’s ($38.64) share price. EXAS was included in 40 notes of analysts from July 24, 2015. The stock has “Buy” rating by Craig Hallum on Thursday, October 1. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned “Hold” rating by Benchmark on Tuesday, October 6. Jefferies maintained it with “Buy” rating and $3500 target in Thursday, June 1 report. The firm earned “Buy” rating on Wednesday, October 7 by Canaccord Genuity. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned “Neutral” rating by Goldman Sachs on Monday, August 15. The firm has “Buy” rating by Cowen & Co given on Wednesday, May 31. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) has “Buy” rating given on Wednesday, July 27 by Jefferies. As per Wednesday, February 22, the company rating was upgraded by TH Capital. The company was maintained on Wednesday, October 26 by Benchmark. As per Wednesday, May 4, the company rating was downgraded by Mizuho.

More important recent EXACT Sciences Corporation (NASDAQ:EXAS) news were published by: Prnewswire.com which released: “Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening” on June 22, 2017, also Prnewswire.com published article titled: “Exact Sciences to host second-quarter 2017 results, annual meeting webcasts …”, Nasdaq.com published: “Why Exact Sciences (EXAS) Could Beat Earnings Estimates Again” on June 28, 2017. More interesting news about EXACT Sciences Corporation (NASDAQ:EXAS) was released by: Fool.com and their article: “Why Exact Sciences Corp. Fell 7.5% In June” with publication date: July 07, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.